Symbol="XENE"
AssetType="Common Stock"
Name="Xenon Pharmaceuticals Inc"
Description="Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, is dedicated to developing therapies to treat patients with neurological disorders in Canada. The company is headquartered in Burnaby, Canada."
CIK="1582313"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="200 - 3650 GILMORE WAY, BURNABY, BC, CA"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="2459861000"
EBITDA="-159223008"
PERatio="None"
PEGRatio="-0.06"
BookValue="10.88"
DividendPerShare="0"
DividendYield="0"
EPS="-2.26"
RevenuePerShareTTM="0.011"
ProfitMargin="0"
OperatingMarginTTM="-240.76"
ReturnOnAssetsTTM="-0.157"
ReturnOnEquityTTM="-0.24"
RevenueTTM="668000"
GrossProfitTTM="-96333000"
DilutedEPSTTM="-2.26"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-1"
AnalystTargetPrice="52.31"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="181.44"
PriceToBookRatio="3.217"
EVToRevenue="136.05"
EVToEBITDA="-16.41"
Beta="1.399"
num_52WeekHigh="43.75"
num_52WeekLow="30.96"
num_50DayMovingAverage="40.59"
num_200DayMovingAverage="37.66"
SharesOutstanding="63562000"
DividendDate="None"
ExDividendDate="None"
symbol="XENE"
open="38.95"
high="39.41"
low="38.28"
price="38.70"
volume="267327.00"
latest_trading_day="2023-07-07"
previous_close="38.92"
change="-0.22"
change_percent="-0.5653%"
aroon_positive_momentum_days="65"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="65"
Volume_recent_avg="388595"
Change_recent_avg="0.02"
Delta_recent_avg="1.44"
Variance_recent_avg="0.72"
Change_ratio_recent_avg="0.03"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="65"
Aroon_momentum_negative="35"
image_negative_thumbnail_id_1="146"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0030.jpeg"
image_negative_thumbnail_id_2="501"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0104.jpeg"
image_neutral_thumbnail_id_1="568"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0031.jpeg"
image_neutral_thumbnail_id_2="567"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0032.jpeg"
image_positive_thumbnail_id_1="652"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0056.jpeg"
image_positive_thumbnail_id_2="698"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0010.jpeg"
image_professor_thumbnail_id_1="1177"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0011.jpeg"
image_professor_thumbnail_id_2="1194"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0028.jpeg"
